Rho-Kinase as a Target for Cancer Therapy and Its Immunotherapeutic Potential.

Kim, Seohyun; Kim, Seong A; Han, Jihoon; Kim, In-San

Kim, Seohyun; Kim, Seong A; Han, Jihoon; Kim, In-San.

Afiliação

Kim S; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Korea.
Kim SA; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Korea.
Han J; KU-KIST Graduate School of Converging Science and Technology, Korea University, Seoul 02841, Korea.
Kim IS; Center for Theragnosis, Biomedical Research Institute, Korea Institute of Science and Technology (KIST), Seoul 02792, Korea.

Int J Mol Sci ; 22(23)2021 Nov 29.

Article em En | MEDLINE | ID: mdl-34884721

Assuntos

Imunoterapia; Terapia de Alvo Molecular; Neoplasias/enzimologia; Quinases Associadas a rho/metabolismo; Animais; Humanos; Neoplasias/imunologia; Neoplasias/terapia; Microambiente Tumoral

Palavras-chave

ROCK inhibitors; Rho-kinase (ROCK); cancer immunotherapy; tumor microenvironment (TME)

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Quinases Associadas a rho / Terapia de Alvo Molecular / Imunoterapia / Neoplasias Limite: Animals / Humans Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google